Bronchiolitis Clinical Pathway, Emergency Department and Inpatient – Suction Bronchodilator Trial
Bronchodilator Trial
Albuterol
Studies have NOT demonstrated a consistent benefit for albuterol treatment in infants with typical bronchiolitis. An albuterol trial may be considered in children with features suggestive of possible asthma (recurrent wheezing, age > 12 months, prior albuterol and/or inhaled corticosteroid use). Other risk factors (family history of asthma, atopy) are not clearly associated with response. If ordering a trial of albuterol document the indication in the note and document response.
Racemic epinephrine
Racemic epinephrine may have transient benefit for children with severe disease but is not a therapy that can be continued at home. Use should be reserved for children with severe disease as a rescue therapy.
Consider Procedure for bronchodilator trial: RT: Score-Treat-Score